Page last updated: 2024-12-07

n-2-hexyl-n-methylpropargylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-2-hexyl-N-methylpropargylamine: has neuroprotective effect against the neurotoxin DSP-4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID132554
CHEMBL ID541079
CHEMBL ID1190540
SCHEMBL ID333192
MeSH IDM0247959

Synonyms (15)

Synonym
n-(2-hexyl)-n-(methyl)propargylamine
n-methyl-n-2-propynyl-2-hexanamine
143347-04-0
n-2-hexyl-n-methylpropargylamine
2-hexanamine, n-methyl-n-2-propynyl-
2-hxmp
bdbm50003144
chembl541079 ,
methyl-(1-methyl-pentyl)-prop-2-ynyl-amine; hydrochloride
n-methyl-n-prop-2-ynylhexan-2-amine
CHEMBL1190540
SCHEMBL333192
n-methyl-n-(prop-2-yn-1-yl)hexan-2-amine
DTXSID80931828
PD134740

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" We have assessed the toxic effects of dopamine and L-DOPA toward catecholaminergic neuroblastoma SH-SY5Y cells and whether R(-)-deprenyl and several structurally related compounds possess antioxidant effects in this system."( R(-)-deprenyl potentiates dopamine-induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells.
Lai, CT; Yu, PH, 1997
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's9 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.15 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (11.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]